Trading Analysis Report: AIP
- Analysis date: 2026-06-01
- Processed decision: Hold
- Price Target: 38.00
I. Analyst Team Reports
Market Analyst
Market Report
Arteris (AIP) traded at $35.95 on May 29, 2026. The local yfinance snapshot showed a 52-week range of $7.56-$38.47, a 50-day average of $25.73, and a 200-day average of $16.77.
Momentum is powerful but extended. yfinance showed a 362.7% one-year return and a 130.7% YTD return, with the stock trading far above both moving averages and close to its 52-week high.
AIP fits the AI and semiconductor queue as semiconductor IP and SoC design software infrastructure. Arteris provides network-on-chip interconnect IP, SoC integration automation, and hardware security assurance that help customers build complex AI, chiplet, automotive, data-center, edge, industrial, and aerospace chips.
Market read: Hold with a $38.00 target. The target is near yfinance median analyst target of $38.00, leaving limited upside after the rally.
Sentiment Analyst
Sentiment Report
Sentiment is constructive on business momentum and AI-chip design exposure.
Q1 2026 revenue was $22.9 million, up 39% year over year. ACV plus royalties reached $92.8 million, up 39%, and RPO was $118.3 million, up 33%.
The business update was strong. Arteris highlighted wins with a global hyperscaler, a memory supplier working on HBM, Renesas R-Car Gen 5, MIPS physical AI collaboration, and additional adoption in space-related systems.
The caution is valuation. yfinance showed price/sales of 21.6x, negative operating margin, and a stock that already sits near the 52-week high after a more than fourfold one-year move.
Sentiment read: Hold. The company is executing, but the market already recognizes the AI-era semiconductor IP story.
News Analyst
News Report
The May 12, 2026 Q1 2026 release is the key current news item.
Arteris reported $22.9 million of Q1 revenue, $7.9 million of trailing-twelve-month variable royalties, $92.8 million of ACV plus royalties, and $118.3 million of RPO. Non-GAAP operating loss improved to $2.5 million from $3.2 million in Q1 2025.
Management raised full-year 2026 expectations to $91.0-$95.0 million of revenue and $5.0-$9.0 million of free cash flow. Q2 2026 guidance calls for $23.0-$24.0 million of revenue and $2.0-$8.0 million of free cash flow.
The February 2026 FY2025 release showed the platform's base: FY2025 revenue was $70.6 million, up 22%, variable royalties rose 50%, and non-GAAP free cash flow was positive $5.3 million.
News read: Arteris is showing demand leverage from AI-enabled chips, chiplets, HBM, automotive, and security verification, but the stock has already priced in a large improvement.
Fundamentals Analyst
Fundamentals Report
Fundamentals show a high-gross-margin semiconductor IP model that is still GAAP unprofitable.
Q1 2026 revenue was $22.9 million, compared with $16.5 million in Q1 2025. Gross profit was $19.7 million, implying a GAAP gross margin of about 85.8%.
Operating expenses were $29.0 million, resulting in $9.3 million operating loss and $8.0 million net loss. Non-GAAP net loss was $1.2 million, or $0.03 per share.
Balance sheet liquidity is adequate but not excessive. At March 31, 2026, cash and cash equivalents were $11.7 million, short-term investments were $26.4 million, and yfinance showed total debt of about $6.7 million.
yfinance showed market cap of approximately $1.66 billion, enterprise value of approximately $1.63 billion, total revenue of approximately $77.0 million, price/sales of 21.6x, gross margin of 88.8%, and operating margin of negative 38.0%.
Fundamental read: attractive software-like economics and improving free cash flow, but valuation requires continued strong ACV, royalty, and revenue growth.
II. Research Team Decision
Bull Researcher
Bull Research
The bull case is that Arteris is becoming a strategic design-infrastructure vendor for the AI semiconductor cycle.
AI chips, chiplets, HBM, automotive compute, physical AI, and aerospace systems require increasingly complex data movement inside SoCs. Arteris' NoC and integration tools address that complexity.
Q1 2026 metrics support the thesis. Revenue grew 39%, ACV plus royalties grew 39%, RPO grew 33%, and trailing-twelve-month variable royalties grew 67%.
The royalty component adds operating leverage if customer chips reach volume. Arteris says customers have shipped more than four billion SoC chips and chiplets incorporating its NoC technology.
The Cycuity acquisition broadens the platform into hardware security verification, a useful capability as chip complexity and cybersecurity requirements rise.
Bull conclusion: if Arteris keeps winning AI, HBM, automotive, and chiplet design programs, revenue and royalties can compound from a small base.
Bear Researcher
Bear Research
The bear case is that the stock has moved faster than fundamentals.
AIP traded near its 52-week high and yfinance showed a 362.7% one-year return. At 21.6x trailing sales, the company needs sustained high growth and margin leverage.
Arteris is still GAAP unprofitable. Q1 2026 operating loss was $9.3 million, net loss was $8.0 million, and the yfinance operating margin was negative 38.0%.
Risks include semiconductor-cycle volatility, longer customer design cycles, revenue recognition timing, dependency on design wins converting into shipped chips, competition from larger EDA and IP vendors, China/geopolitical exposure, product errors, and integration risk from Cycuity.
Bear conclusion: Arteris is a good AI-semiconductor infrastructure story, but valuation leaves little margin for slower bookings, delayed royalties, or weaker semiconductor spending.
Research Manager
Research Manager Synthesis
The bull case is strong Q1 growth, record ACV plus royalties, record RPO, royalty expansion, exposure to AI chips and chiplets, and improving free cash flow guidance.
The bear case is premium valuation, large stock appreciation, continued GAAP losses, competition, design-cycle risk, and limited upside to consensus targets.
The correct conclusion is Hold. AIP deserves a premium, but the stock is close to the current fair-value range after a large rally.
Synthesis: assign Hold with a $38.00 target.
III. Trading Team Plan
Trader
Trader View
AIP is in a steep uptrend. The latest $35.95 price is above the $25.73 50-day average and $16.77 200-day average, and close to the $38.47 52-week high.
Upside trigger: stronger Q2 results, another FY2026 guidance raise, hyperscaler or HBM design-win disclosure, royalty acceleration, positive free cash flow, or broader AI-semiconductor software multiple expansion.
Downside trigger: bookings slowdown, lower ACV growth, weaker royalty conversion, higher operating expense, semiconductor budget pressure, or valuation compression.
Trading plan: Hold with a $38.00 6-12 month target. New entries need either a pullback or a fresh acceleration signal.
IV. Risk Management Team Decision
Aggressive Analyst
Aggressive Risk View
Aggressive investors can hold AIP for exposure to AI-chip design complexity.
The upside is that Arteris' technology may become more valuable as AI chips, chiplets, HBM, and automotive compute architectures become harder to integrate securely and efficiently.
Aggressive conclusion: Hold, with tactical adds only if revenue and ACV growth continue above guidance.
Conservative Analyst
Conservative Risk View
Conservative investors should avoid chasing AIP at the current valuation.
The business has high gross margins and useful strategic exposure, but it is still GAAP unprofitable and priced at more than 20x trailing sales after a sharp rally.
Conservative conclusion: Hold existing positions or wait for a better entry point.
Neutral Analyst
Neutral Risk View
The neutral view is Hold.
AIP has real AI-semiconductor infrastructure exposure and improving operating metrics, but the stock already reflects strong optimism. A $38.00 target aligns with current analyst targets and preserves valuation discipline.
Neutral conclusion: Hold with a $38.00 target.
V. Portfolio Manager Decision
Portfolio Manager
Portfolio Manager Decision
Rating: Hold Price Target: 38.00
Horizon: 6-12 months Current Price Reference: $35.95 on 2026-05-29
Arteris is rated Hold. It is included in the AI and semiconductor queue because it provides semiconductor technology for the AI era, including network-on-chip interconnect IP, SoC software integration automation, and hardware security assurance.
The latest major financial update is Q1 2026 results. Revenue was $22.9 million, up 39% year over year. Trailing-twelve-month variable royalties were $7.9 million, up 67%, ACV plus royalties were $92.8 million, up 39%, and RPO was $118.3 million, up 33%.
Profitability is improving but not yet complete. Q1 2026 operating loss was $9.3 million, partly due to one-time acquisition-related items, and non-GAAP operating loss was $2.5 million. Net loss was $8.0 million, while non-GAAP net loss was $1.2 million.
Guidance is constructive. Management guided Q2 2026 revenue to $23.0-$24.0 million and free cash flow to $2.0-$8.0 million. Updated FY2026 guidance calls for $91.0-$95.0 million of revenue and $5.0-$9.0 million of free cash flow.
The strategic setup is compelling. Q1 highlights included a global hyperscaler expansion, a leading memory supplier accelerating HBM development, Renesas R-Car Gen 5 deployment, collaboration with MIPS for physical AI, and more adoption in aerospace and space-related systems. Arteris also closed the Cycuity acquisition, expanding into semiconductor security verification software.
yfinance showed a latest price of $35.95, market cap of approximately $1.66 billion, enterprise value of approximately $1.63 billion, 52-week range of $7.56-$38.47, total revenue of approximately $77.0 million, price/sales of 21.6x, gross margin of 88.8%, operating margin of negative 38.0%, total cash of approximately $38.1 million, total debt of approximately $6.7 million, mean analyst target of $37.75, and median analyst target of $38.00.
The main risks are premium valuation, semiconductor-cycle volatility, customer design-cycle timing, royalty conversion, revenue recognition timing, competition from larger EDA and IP vendors, product defects, Cycuity integration risk, and geopolitical exposure.
The $38.00 target reflects strong AI-chip design infrastructure exposure and improving financial metrics, but keeps the rating at Hold because valuation is already demanding after a large rally.